Buchwald-Hartwig reaction: an overview
Pd-catalyzed amination reaction of aryl halides has attracted much attention in recent years.
This review underscores selected important recent developments in the catalysis of one of …
This review underscores selected important recent developments in the catalysis of one of …
The alpha keto amide moiety as a privileged motif in medicinal chemistry: current insights and emerging opportunities
M Robello, E Barresi, E Baglini, S Salerno… - Journal of Medicinal …, 2021 - ACS Publications
Over the years, researchers in drug discovery have taken advantage of the use of privileged
structures to design innovative hit/lead molecules. The α-ketoamide motif is found in many …
structures to design innovative hit/lead molecules. The α-ketoamide motif is found in many …
[图书][B] Privileged structures in drug discovery: medicinal chemistry and synthesis
L Yet - 2018 - books.google.com
A comprehensive guide to privileged structures and their application in the discovery of new
drugs The use of privileged structures is a viable strategy in the discovery of new medicines …
drugs The use of privileged structures is a viable strategy in the discovery of new medicines …
Good night and good luck: norepinephrine in sleep pharmacology
HA Mitchell, D Weinshenker - Biochemical pharmacology, 2010 - Elsevier
Sleep is a crucial biological process that is regulated through complex interactions between
multiple brain regions and neuromodulators. As sleep disorders can have deleterious …
multiple brain regions and neuromodulators. As sleep disorders can have deleterious …
Overexpression of CB2 cannabinoid receptors decreased vulnerability to anxiety and impaired anxiolytic action of alprazolam in mice
MS García-Gutiérrez… - Journal of …, 2011 - journals.sagepub.com
Mice overexpressing CB2r (CB2xP) were exposed to open field (OF), light–dark box (LDB)
and elevated plus maze (EPM) tests. Corticotropin-releasing factor (CRF) and pro …
and elevated plus maze (EPM) tests. Corticotropin-releasing factor (CRF) and pro …
Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects
EM Marco, MS García-Gutiérrez… - Frontiers in behavioral …, 2011 - frontiersin.org
Public concern on mental health has noticeably increased given the high prevalence of
neuropsychiatric disorders. Cognition and emotionality are the most affected functions in …
neuropsychiatric disorders. Cognition and emotionality are the most affected functions in …
Tachykinin receptors as therapeutic targets in stress-related disorders
K Ebner, SB Sartori, N Singewald - Current pharmaceutical …, 2009 - ingentaconnect.com
The first report demonstrating the therapeutic efficacy of an orally applied neurokinin-1
(NK1) receptor antagonist in depression was published 10 years ago. Although there were …
(NK1) receptor antagonist in depression was published 10 years ago. Although there were …
Activation-induced regulation of GABAA receptors: is there a link with the molecular basis of benzodiazepine tolerance?
MC Gravielle - Pharmacological Research, 2016 - Elsevier
Benzodiazepines have been used clinically for more than 50 years to treat disorders such as
insomnia, anxiety, and epilepsy, as well as to aid muscle relaxation and anesthesia. The …
insomnia, anxiety, and epilepsy, as well as to aid muscle relaxation and anesthesia. The …
Discovery of allosteric modulators for GABAA receptors by ligand-directed chemistry
K Yamaura, S Kiyonaka, T Numata, R Inoue… - Nature Chemical …, 2016 - nature.com
The fast inhibitory actions of γ-aminobutyric acid (GABA) are mainly mediated by GABAA
receptors (GABAARs) in the brain. The existence of multiple ligand-binding sites and a lack …
receptors (GABAARs) in the brain. The existence of multiple ligand-binding sites and a lack …
Anxiolytic-like Effects of N,N-Dialkyl-2-phenylindol-3-ylglyoxylamides by Modulation of Translocator Protein Promoting Neurosteroid Biosynthesis
F Da Settimo, F Simorini, S Taliani… - Journal of medicinal …, 2008 - ACS Publications
Novel N, N-disubstituted indol-3-ylglyoxylamides (1− 56), bearing different combinations of
substituents R1− R5, were synthesized and evaluated as ligands of the translocator protein …
substituents R1− R5, were synthesized and evaluated as ligands of the translocator protein …